API Ubenimex CAS 58970 76 6

Sell Lead

Pharmaceuticals and Healthcare

18-Oct-2018

API
Item PRODUCTS CAS NO SPECIFICATION
1 Moxifloxacin Hydrochloride 186826-86-8 USP
2 Dextran 40 9004-54-0 BP2012 JP16 USP35
3 Moxonidine 75438-57-2 ChP2015 EP7.0 JP16
4 Alanyl glutamine 39537-23-0 EP7.0
5 Ubenimex 58970-76-6 ChP2015 JP17
6 Epalrestat 82159-09-9 ChP2015 JP16
7 Tirofiban hydrochiloride 142373-60-2 JP16
8 Iopromide 73334-07-3 In-Home Standard
9 Gadodiamide 131410-48-5 EP7.0 USP36
10 Topiroxostat 577778-58-6 USP36
11 Vonoprazan fumarate 1260141-27-2 In-Home Standard
12 Cefotiam hydrochloride 66309-69-1 In-Home Standard
13 Cefotiam hexetil hydrochloride 95789-30-3 In-Home Standard
14 Latamoxef sodium 64953-12-4 JP16
15 Flomoxef sodium 92823-03-5 JP17
16 L(-)-Malic acid 97-67-6 In-Home Standard
17 Satranidazole 56302-13-7 In-Home Standard
18 Tofogliflozin 1201913-82-7 In-Home Standard
Intermediates
19 Diethyl L-malate 691-84-9 In-Home Standard
20 4-(4-chlorobutyl) pyridine,hydrochloride 149463-65-0 In-Home Standard

Report Error
More leads from this companyMore »
Offered by
Logo - XI'An Wanlong Pharmaceutical Co., Ltd
XI'An Wanlong Pharmaceutical Co., Ltd

Xi'an (China)

Pharmaceuticals and Healthcare

Manufacturer

1995

International

About Company

Xi’an Wanlong pharmaceutical Co., Ltd was founded in 1995 and it is comprehensive modern pharmaceutical enterprise which mainly produces formulations, API and intermediates,GMP&DMF available. The company’s registered capital reaches CNY 75 million. The building area of company is over 2000000 square meters. All the work shops are compliant with GMP requirements. There are more than 700 employees including over 70 RD staffs?20 experienced production management people and 8 senior professional registration specialists. Having a dynamic, high-quality team, which ensures our company sustainable and stable development. We produce tablets, capsule, granules, injection and API, total 49 drug approval numbers and other intermediates. There are 4 API workshops, and two solid preparation plants, injection plants with GMP. Annual production capacity of 100 tons of raw material, solid dosage form annual output of 3 billion, injection annual output 1.3 billion bags. The drug products are widely used in the most provinces of china, and API exports to all over the world. We have the rights of self-operated import and export and welcome the clients around the world to cooperate with us. XI'AN WANLONG PHARMACEUTICAL CO., LTD specializes in the developing, marketing and manufacturing of Active Pharmaceutical Ingredients, intermediates. We have full experience on the pharmaceutical business. We have good relations with many domestic and abroad chemical and pharmaceutical factories and professional institutes, so we have extensive channel for various information. Our company can serve as your partner and your company's commercial bridge to the pharmaceutical marketplace. We are manufacturer, which are strong in developing, custom manufacturing and executing customer's highly specialized synthesis. With the principal of benefit to each other, we have been very successful on contract manufacturing products for some reputed customers, especially on pharmaceutical intermediates. Flexible and multi-use workshops, good facilities meeting cGMP, lab to pilot to industrial scales of synthesis capacities, and strict quality assurance system made us as a reliable supplier of quality products. With the support of our own plant and many good relation partners, our products have been exported to many countries and areas in the world. Based on the good quality and excellent services, we have gained high popularity among our end-users all over the world.. view more »

Copyright © 2000 - 2017 IndiaBizClub. All rights reserved